Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 26, 2017
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - May 26, 2017

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

5/26/17 - "A Therapeutic Protocol for Treating Ovarian Cancer" in Patent Application Approval Process (USPTO 20170119727)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors Kremmidiotis, Gabriel; BIBBY, David C.; RISCHIN, Danny, filed on May 30, 2014, was made available online on May 11, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Bionomics
5/26/17 - "Extended-Release Topiramate Capsules" in Patent Application Approval Process (USPTO 20170119808)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors BETTERMAN, Sarah Michelle; TANTRY, Jaidev Srinivas; PATRICK, Laura Marie, filed on November 21, 2016, was made available online on May 11, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is
5/26/17 - "SELF-EMULSIFYING COMPOSITION OF W3 FATTY ACID" in Patent Application Approval Process (USPTO 20170119724)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors FUJII, Hirosato; YAMAGATA, Motoo, filed on January 18, 2017, was made available online on May 11, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Mochida Pharmaceutical Co.,
5/26/17 - Abbott Laboratories' Trademark Application for "PEDIASURE HARVEST" Filed
By a News Reporter-Staff News Editor at Health& Medicine Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "PEDIASURE HARVEST" by Elisa M. Valenzona, representing Abbott Laboratories. The owner/registrar information for this application is: Elisa M. Valenzona, Abbo
5/26/17 - Abbott Laboratories' Trademark Application for "TRUEID" Filed
By a News Reporter-Staff News Editor at Health& Medicine Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "TRUEID" by Michele H. Bowman, representing Abbott Laboratories. The owner/registrar information for this application is: Michele H. Bowman, Abbott Laboratori
5/26/17 - Abbott Labs: A genomic disease management company, engages in the development and marketing of clinical laboratory products, which provide information critical to the evaluation and management of cancer, prenatal disorders, and other genetic diseases
It currently markets seven U.S. Food and Drug Administration or foreign cleared or approved clinical products in addition to distributing over 300 Analyte Specific Reagent and research products through its direct sales operations in the United States and Europe and a worldwide distribution network covering 59 countries. Mary Szela joined Melinta...
5/26/17 - Abeona Therapeutics receives FDA orphan designation for gene therapy
The FDA has granted Orphan Drug Designation for Abeona Therapeutics's EB-101 gene therapy program for patients with dystrophic epidermolysis bullosa...
5/26/17 - Abeona Therapeutics Receives FDA Orphan Drug Designation for EB-101 Gene Therapy Product for Patients with Epidermolysis Bullosa [Tehran Times (Iran)]
Abeona Therapeutics Inc., a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare diseases, announced today that the FDA has granted Orphan Drug Designation for Abeonas EB-101 gene therapy program for patients with dystrophic epidermolysis bullosa, including recessive dystrophic...
5/26/17 - Active Pharmaceutical Ingredients Market Outlook and Worldwide Forecast to 2027
Global Active Pharmaceutical Ingredients Information, by types, by applications, by manufacturing method-Forecast 2027 Pune, India 05/26/2017 Market Synopsis of Active pharmaceutical ingredients Market:. Active Pharmaceutical Ingredient is the integral part of the drug because of which the disease gets cured. Request a Sample Report@...
5/26/17 - Advanced Accelerator Applications (AAAP) Appoints Christine Mikail to Board of Directors [National News Agency (Lebanon)]
Advanced Accelerator Applications S.A. today announced that Christine Mikail, J.D. has joined the Companys board of directors as an independent non-executive director. Ms. Mikail brings both a broad legal skillset and substantial business development experience in the pharmaceutical industry, stated Stefano Buono, Chief Executive Officer of AAA.
5/26/17 - Advanced Accelerator Applications Appoints Christine Mikail to Board of Directors [Oman News Agency]
-Advanced Accelerator Applications S.A., an international specialist in Molecular Nuclear Medicine, today announced that Christine Mikail, J.D. has joined the Companys board of directors as an independent non-executive director. Ms. Mikail brings both a broad legal skillset and substantial business development experience in the pharmaceutical indus
5/26/17 - AERI Is Awesome, GWPH Abuzz, FDA Panel Nod For PBYI [Sport360]
Today`s Daily Dose brings you news about Aerie Pharma`s positive efficacy results from phase III study of its glaucoma drug candidate Roclatan; Alnylam`s public offering and FDA panel`s support for approval of Puma`s breast cancer drug Neratinib. Shares of Aerie Pharmaceuticals Inc. climbed more than 27% in extended trading on Wednesday, following.
5/26/17 - Aerie Pharmaceuticals Raises $125 Million in ATM Sales and Upsized Follow-On Offering
Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, today announced that it has priced its registered underwritten public offering of $75 million of shares of its common.
5/26/17 - Agency Information Collection Activities: Proposed Collection; Comment Request; Applications for Food and Drug Administration Approval To Market a...
SUMMARY: The Food and Drug Administration is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995, Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed...
5/26/17 - Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR) Files An 8-K Submission of Matters to a Vote of Security Holders
Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR) Files An 8-K Submission of Matters to a Vote of Security Holders Item5.07 Submission of Matters to a Vote of Security Holders. On May24, 2017, Alder BioPharmaceuticals, Inc. (the Company) held its 2017 Annual Meeting of Stockholders at the offices of Cooley LLP at 1700 Seventh Avenue, Suite 1900, Seattle
5/26/17 - American Discount Pharmacy Corp./ UPS: Has been featured on Fox and Wink TV for having some of the best prices on FDA-approved and USA Wholesaler medications
American Discount Pharmacy Corp./ UPS. American Discount Pharmacy has been featured on Fox and Wink TV for having some of the best prices on FDA- approved and USA Wholesaler medications. Their is a prototype UPS located within the store of American Discount Pharmacy Corp./ UPS and we are proud to be a part of this unique combination.
5/26/17 - ANI Pharmaceuticals Announces Launch of Pindolol Tablets
By a News Reporter-Staff News Editor at Drug Week ANI Pharmaceuticals, Inc. announced the launch of Pindolol Tablets, 5 mg and 10 mg, which is used in the treatment of hypertension. Arthur S. Przybyl, ANI's President and CEO stated, "We are excited to launch the first product from our partnership with IDT Australia Ltd., which we entered in Augus
5/26/17 - Apellis Receives EMA Orphan Drug Designation for APL-2 in PNH
By a News Reporter-Staff News Editor at Drug Week Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on inhibition of the complement system, announced that the European Medicines Agency has granted orphan medicinal product designation to APL-2, a complement C3 inhibitor, in the treatment of patients with paroxysmal.
5/26/17 - Araim Pharmaceuticals' Cibinetide ARA 290 Regenerates Small Nerve Fibers and Improves Neuropathic Clinical Symptoms in the Orphan Disease of...
Araim Pharmaceuticals' Cibinetide ARA 290 Regenerates Small Nerve Fibers and Improves Neuropathic Clinical Symptoms in the Orphan Disease of Sarcoidosis. By a News Reporter-Staff News Editor at Health& Medicine Week Araim Pharmaceuticals Inc., announced the publication of Phase 2 b study results in small fiber neuropathy of the Company's lead com
5/26/17 - Arbutus Biopharma Corp. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)] (May. 4, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Arbutus Biopharma Corp. was posted on May 4, 2017. The SEC file number is 0001628280-17-004968.. A U.S. Securities and Exchange Commission filing is a formal do
5/26/17 - Arbutus Biopharma Corp. Files SEC Form 8-K, Current Report (May. 4, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Arbutus Biopharma Corp. was posted on May 4, 2017. The SEC file number is 0001171843-17-002663.. A U.S. Securities and Exchange Commission filing is a formal do
5/26/17 - Arbutus Biopharma Corporation (NASDAQ:ABUS) Files An 8-K Submission of Matters to a Vote of Security Holders
Arbutus Biopharma Corporation (NASDAQ:ABUS) Files An 8-K Submission of Matters to a Vote of Security Holders Item 5.07. Submission of Matters to a Vote of Security Holders. On May 24, 2017, the Corporation held its Annual General Meeting of Shareholders. At the meeting, shareholders voted in favor of all items of business, as indicated below: [?]
5/26/17 - Array Biopharma Inc. Files SEC Form 8-K, Current Report (May. 8, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Array Biopharma Inc. was posted on May 8, 2017. The SEC file number is 0001144204-17-024983.. A U.S. Securities and Exchange Commission filing is a formal docum
5/26/17 - AstraZeneca delivers new data on expanding portfolio of cancer medicines at 2017 American Society of Clinical Oncology (ASCO) Annual Meeting
Release date- 26052017- AstraZeneca, along with its global biologics research and development arm, MedImmune, will demonstrate how it is rapidly delivering on the Company's science-led strategy for transformational cancer medicine development at the 2017 American Society of Clinical Oncology Annual Meeting in Chicago, US, 2-6 June 2017.
5/26/17 - Autism study questions and answers [The San Diego Union-Tribune]
May 26 This question and answer article about the autism clinical trial led by Robert Naviaux, professor of genetics in the departments of medicine, pediatrics and pathology of the University of California San Diego, was provided by the university. It describes the rationale for using the old sleeping sickness drug suramin and implications if the
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415